Law Enforcement and the Prescriber Enforcement Action Protocol

Similar documents
9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort

White Collar Courier: Delivering News and Providing Guidance in White Collar Matters

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

Update on the Opioid Crisis

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors

We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit

Prescription Monitoring Program: Law Enforcement Responsibilities National Conference of State Legislatures

Prescription for Progress Study conducted by the Siena College Research Institute April 10 - May 4, Stakeholders - MOE +/- 4.

Presentation Overview

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data

Case 1:13-cr SCJ-JFK Document 1 Filed 01/22/13 Page 1 of 17 SEALED ATLANTA DIVISION

Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and

Opioids drive continued increase in drug overdose deaths

Prescription Drug Abuse Task Force Rx Report Card

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

Prescribing Controlled Substances and the PDMP

NC General Statutes - Chapter 90 Article 5E 1

University of Pittsburgh

Pharmaceutical Diversion in Medicare. HHS Office of Inspector General: Background

Prescription Monitoring Program (PMP)

Pennsylvania Prescription Drug Monitoring Program Trends,

THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL

WA PMP Access by Public Payers. PDMP North Regional Meeting St. Louis, MO April 23-24

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89

MARYLAND BOARD OF PHARMACY

Prescription Drugs: Issues in Treatment, Supervision and Case Management

Foster Dennin Page 1 AP Lang 3/1/17 Research Paper Recreational Marijuana: Yes or No?

Confronting the Opioid Crisis at the State Level

Prescription Painkiller Abuse in Wisconsin Sharing a Dose of Reality. Brad Schimel Wisconsin Attorney General

Referred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada.

6/19/2012. Disappearing Drugs. Disappearing Drugs: Protect Yourself from Diversion. Disappearing Drugs: Protect Yourself from Diversion

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Aligning Pain Management Community Public Health Presentation

Reversing the Opioid Epidemic

A National Challenge with a Community Solution. Officer Al Fear Eastern Iowa Heroin Initiative

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

Crowe Healthcare Webinar Series

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

Schedules of Controlled Substances: Temporary Placement of U into. AGENCY: Drug Enforcement Administration, Department of Justice.

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW HOUSE BILL 243

REVERSING THE OPIOID EPIDEMIC: STRATEGIES TO SAVE LIVES

Controlled Substances Program. For Academic Units

Clinical breakout sessions announced. Learn More

Louisiana s Heroin Epidemic and the Overuse of Opioids. William Beau Clark, MD East Baton Rouge Parish Coroner

THE CONNECTICUT LAW ENFORCEMENT CONFERENCE TO ADDRESS OPIOID MISUSE PROTECT

2016 Dr. Douglas H. Kay CPE Symposium

ACCG Mental Health Summit

Schedules of Controlled Substances: Placement of Furanyl fentanyl, 4- Fluoroisobutyryl fentanyl, Acryl fentanyl, Tetrahydrofuranyl fentanyl, and

Review of Controlled Drugs and Substances Act

Conversations With. The Honorable Dick Thornburgh The Honorable Rudolph W. Giuliani. The Issue: Prescription Drug Abuse

Physician Off-Label Marketing. FDA Regulations Governing Manufacturers

Schedules of Controlled Substances: Temporary Placement of Furanyl Fentanyl. AGENCY: Drug Enforcement Administration, Department of Justice

Changes to the Eighth Edition

Federal Firearm Prohibitions

Outline. Decreasing total opioid prescriptions Decreasing benzodiazepine and opioid co-prescription. Increasing community awareness of opioid risks

Donald K. Hallcom, Ph.D. March 13, 2014

PATIENT SIGNATURE: DOB: Date:

Work Session VIII: Legalized Marijuana. Douglas J. Friednash City Attorney Denver, Colorado

Drug Diversion Recognition and Prevention in a Hospital Setting. Natalie Tuttle PharmD, BCPS, DPLA University of Toledo Medical Center

Technical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort

October 8, Michael Botticelli Deputy Director Office of National Drug Control Policy. Washington, D.C Dear Deputy Director Botticelli:

Top 10 narcotic pain pills

Methadone Treatment. in federal prison

OXYCONTIN Diversion & Abuse Drug Enforcement Administration Office of Diversion Control October 2003

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

Using CURES to combat prescription drug abuse/misuse

The Opioid Scourge DR. CAROLINE CARNEY CHIEF MEDICAL OFFICER

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

Statement Of. The National Association of Chain Drug Stores. For. United States Senate Caucus on International Narcotics Control.

The Criminal Justice Response to Opioid Trafficking in Michigan

CONTACT INFORMATION WHY DO WE CARE?

Methadone Treatment. in federal prison

Prescription Opioid Overdose in Oregon: A public health perspective

Our Core Thoughts on Dealing with the Opioid Addiction Crisis. Meghan McNelly, PharmD, MHA, FACHE Suzette Song, MD Joseph Alhadeff, MD

Methods, Trends and Solutions for Drug Diversion

Rule Governing the Prescribing of Opioids for Pain

ASPMN Conference Baltimore, Maryland

Prescription Drug Abuse National Perspective

Florida s Roadmap to End its Prescription Drug Abuse Epidemic Florida Attorney General Pam Bondi One Page Summary

Teaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic

Methadone Grows as Killer Drug

Maine Survey Results

Prescription Drug Take-Back Program Q s and A s

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.

Liability, Informed Consent, and Risk Management 15 Thoughts for Pain Management Physicians

Perspective from Kentucky: Using PMP Data in Drug Diversion Investigations

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Sample Street Prices*

LEGAL ISSUES IN MARKETING A DENTAL PRACTICE: REFERRAL GIFTS AND GROUPON DISCOUNTS. Message from the ADA Legal Division October 7, 2011

ASSEMBLY, No. 542 STATE OF NEW JERSEY. 218th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION

Confronting the Opioid Epidemic

Controlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control

The Controlled Substances Act: Regulatory Requirements

SWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective

Tracker e-prescribing 101. The Complete Guide

Transcription:

Law Enforcement and the Prescriber Enforcement Action Protocol Ken Clark U.S. Department of Justice United States Attorney s Office District of Maryland

Opioid Abuse Approx 2.6 fatal overdoses per day in Baltimore City. Unofficial heroin/fentanyl 2018 data (through 10/19/18)

Opioid Abuse Approx 6.9 fatal overdoses per day in the State of Maryland. Unofficial 2018 data (through 10/19/18)

Opioid Abuse Every 3 ½ Hours Unofficial heroin/fentanyl 2018 data (through 10/19/18)

Roadmap

Who Are We?

USAO Maryland More than 80 Assistant US Attorneys Northern and Southern Divisions

USAO Maryland

USAO Maryland

USAO Maryland

USAO Maryland

USAO Maryland

USAO Maryland

USAO Maryland Fraud and Public Corruption Major Crimes National Security Violent Crimes Narcotics Asset Forfeiture Civil Greenbelt

Opioid Abuse

USAO Maryland - Narcotics

USAO Maryland - Narcotics

USAO Maryland - Narcotics

USAO Maryland - Narcotics

Isn t This Supposed To Be About Prescribers?

Providers

Providers

Target: Drug Diverters

Opioid Abuse Four out of five (heroin) addicts say they came to the drug from prescription pain killers. M. Calabresi Time Magazine, June 2015 The Price of Relief, Why America Can t Kick Its Painkiller Problem

PROVIDERS

The Violations: Potential Criminal Charges Drug Distribution (21 U.S.C. 841 et al.) Ultimate issue: Prescription must be issued for a legitimate medical purpose by an individual acting in the usual course of professional practice. 21 C.F.R. 1306.04(a) If not, they are DRUG DEALERS and same criminal penalties apply Healthcare Fraud (18 U.S.C. 1347) Evidence of: 1) Fraudulent billing under National Provider Identifier (NPI); 2) Fraudulent up-coding for examinations; 3) Unnecessary procedures or tests for the purpose of generating revenue Also can charge Mail & Wire Fraud (18 U.S.C. 1341, 1343) Anti-Kickback Statute (42 U.S.C. 1320a-7b) Knowingly and willfully offering, paying, soliciting or receiving ANY remuneration (does not have to be $) AT LEAST IN PART to induce, or in exchange for, some medical good or service that is PAID FOR AT LEAST IN PART by a federal healthcare program Money Laundering (18 U.S.C. 1956, 1957) Hiding the $$

Target: Drug Diverters Diversion of pharmaceutical drugs for financial gain. Pharmacies, physicians, health professionals Script mills to manufacture fraudulent prescriptions used to obtain pharmaceutical products Pharmacies filling known bogus scripts Physicians writing prescriptions with no legitimate medical reasons writers Doctor/ER Shopping drug seekers

Target: Pill Mills Operators Common Traits/Red Flags A doctor or prescriber who: Writes an unusually high amount of certain prescriptions. Doesn t ask a lot of questions. Does not subject patients to urinalysis testing. Does not discharge patients despite multiple abuses or signs of abuse. See patients for very short amounts of time (30 seconds). Accepts cash in exchange for prescriptions. Is willing to write multiple prescriptions at one visit and/or writes a dangerous combination of scheduled narcotics. Has patients lined up outside the practice each day. Has groups of patients showing up in vans, and often coming from long distances. Has a high number of patient overdoses and/or intoxication deaths.

Target: Pill Mill Operators

Wire Taps OWNER said, I messed up the first time because I thought that only one would do that for me, now I know it wouldn t so I m opening multiple ones to make a lot of money really fast ASSOCIATE said, all stems from them doctors writin people out shit that they don t really need it s s**t that they don t really need. ASSOCIATE said, people in these day and age dog are just lookin at as like you know all these pills are just f***in killin people and it s destroyin lives and s**t OWNER said, I will make you a promise when I say I m openin more, It s not to be forever, it, it s just gonna be for a couple years, save up the money I need cause it the more clinics I have, the more money I can stack up

Providers Investigate gather the data Search Warrants documents and computer systems Arrests providers, employees, dealers DEA / Medical licenses

Issue: Disruption of Practice

Solution: Prescriber Enforcement Action Protocol

Disclaimer

Fran

Overview of Protocol

Framework

Living Document

Resource

Purpose

Notice Varies What? Where? When? Goal: Information Sharing

Example Notice

What Next?

Problem: Identifying Scope

Problem: Identifying Scope Aggregate PDMP data Potentially specific PDMP data Doctor s office files

Goal: Address Urgent Medical Issues

Framework

Living Document

Resource

Complicated problem

Do no harm

Questions If you have questions, please contact: Ken Clark Maryland Opioid Fraud and Abuse Initiative Coordinator U.S. Department of Justice United State s Attorney s Office Kenneth.Clark@usdoj.gov (410) 209-4800